Jul 16, 2021· Comment from Association for Accessible Medicines· FDA-2021-D-0166-0010
Filed on regulations.gov — full text not in the inline record.
FDANonrulemakingFDA-2021-D-0166
ICH Q12: Implementation Considerations for FDA-Regulated Products; Draft Guidance for Industry; Availability
RIN
—
Last modified
Jan 11, 2023
Comment window
closed 1750d ago
Association for Accessible Medicines filings
2
Activity
Association for Accessible Medicines filed 2 comments on this docket between Jul 15, 2021 and Jul 16, 2021. 0 other organizations filed here. The comment window closed 1750d ago.
What Association for Accessible Medicines filed (2)
Jul 15, 2021· Comment from Association for Accessible Medicines - updated version available as FDA-2021-D-0166-0010· FDA-2021-D-0166-0007
Comments from the Association for Accessible Medicines regarding Docket No: FDA-2018-D-0166 ICH Q12: Implementation Considerations for FDA-Regulated Products, Guidance for Industry;
Abstract
No abstract recorded.
View on regulations.gov →Co-filers (0)
See everyone who commented →- Association for Accessible MedicinesTHIS ORG2 filings · confidence 97%